Amarin Corporation Statistics
Total Valuation
AMRN has a market cap or net worth of $306.65 million. The enterprise value is $12.29 million.
Important Dates
The next estimated earnings date is Wednesday, May 6, 2026, before market open.
| Earnings Date | May 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AMRN has 20.80 million shares outstanding. The number of shares has increased by 0.99% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 20.80M |
| Shares Change (YoY) | +0.99% |
| Shares Change (QoQ) | +0.11% |
| Owned by Insiders (%) | 3.67% |
| Owned by Institutions (%) | 14.69% |
| Float | 18.35M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 5.92 |
| PS Ratio | 1.44 |
| Forward PS | 1.72 |
| PB Ratio | 0.67 |
| P/TBV Ratio | 0.69 |
| P/FCF Ratio | 45.58 |
| P/OCF Ratio | 45.58 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.06 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 1.83 |
Financial Position
The company has a current ratio of 3.34, with a Debt / Equity ratio of 0.02.
| Current Ratio | 3.34 |
| Quick Ratio | 2.21 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | 1.22 |
| Interest Coverage | -1,991.57 |
Financial Efficiency
Return on equity (ROE) is -8.21% and return on invested capital (ROIC) is -8.05%.
| Return on Equity (ROE) | -8.21% |
| Return on Assets (ROA) | -1.29% |
| Return on Invested Capital (ROIC) | -8.05% |
| Return on Capital Employed (ROCE) | -2.93% |
| Weighted Average Cost of Capital (WACC) | 8.54% |
| Revenue Per Employee | $2.67M |
| Profits Per Employee | -$484,975 |
| Employee Count | 80 |
| Asset Turnover | 0.32 |
| Inventory Turnover | 0.51 |
Taxes
In the past 12 months, AMRN has paid $2.75 million in taxes.
| Income Tax | 2.75M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +66.74% in the last 52 weeks. The beta is 0.82, so AMRN's price volatility has been lower than the market average.
| Beta (5Y) | 0.82 |
| 52-Week Price Change | +66.74% |
| 50-Day Moving Average | 14.98 |
| 200-Day Moving Average | 15.62 |
| Relative Strength Index (RSI) | 49.40 |
| Average Volume (20 Days) | 58,643 |
Short Selling Information
The latest short interest is 446,956, so 3.12% of the outstanding shares have been sold short.
| Short Interest | 446,956 |
| Short Previous Month | 438,392 |
| Short % of Shares Out | 3.12% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 4.75 |
Income Statement
In the last 12 months, AMRN had revenue of $213.65 million and -$38.80 million in losses. Loss per share was -$1.87.
| Revenue | 213.65M |
| Gross Profit | 120.87M |
| Operating Income | -13.94M |
| Pretax Income | -36.05M |
| Net Income | -38.80M |
| EBITDA | -10.91M |
| EBIT | -13.94M |
| Loss Per Share | -$1.87 |
Full Income StatementBalance Sheet
The company has $302.59 million in cash and $8.23 million in debt, with a net cash position of $294.36 million or $14.15 per share.
| Cash & Cash Equivalents | 302.59M |
| Total Debt | 8.23M |
| Net Cash | 294.36M |
| Net Cash Per Share | $14.15 |
| Equity (Book Value) | 459.28M |
| Book Value Per Share | 22.07 |
| Working Capital | 455.42M |
Full Balance SheetCash Flow
| Operating Cash Flow | 6.73M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 3.03M |
| Net Borrowing | n/a |
| Free Cash Flow | 6.73M |
| FCF Per Share | $0.32 |
Full Cash Flow StatementMargins
Gross margin is 56.57%, with operating and profit margins of -6.53% and -18.16%.
| Gross Margin | 56.57% |
| Operating Margin | -6.53% |
| Pretax Margin | -16.87% |
| Profit Margin | -18.16% |
| EBITDA Margin | -5.11% |
| EBIT Margin | -6.53% |
| FCF Margin | 3.15% |
Dividends & Yields
AMRN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.99% |
| Shareholder Yield | -0.99% |
| Earnings Yield | -12.65% |
| FCF Yield | 2.19% |
Analyst Forecast
The average price target for AMRN is $12.00, which is -18.59% lower than the current price. The consensus rating is "Strong Sell".
| Price Target | $12.00 |
| Price Target Difference | -18.59% |
| Analyst Consensus | Strong Sell |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | -0.68% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 11, 2025. It was a reverse split with a ratio of 1:20.
| Last Split Date | Apr 11, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
AMRN has an Altman Z-Score of -1.7 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.7 |
| Piotroski F-Score | 5 |
